Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_assertion description "[As inhibition of the PD-1/PD-L1 pathway is pursued as a therapeutic option for viral infections, potential effects of such a blockade on development of autoimmune responses in the CNS should be considered.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_assertion evidence source_evidence_literature NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_assertion SIO_000772 19828602 NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_assertion wasDerivedFrom befree-20140225 NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_assertion wasGeneratedBy ECO_0000203 NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP419539.RA2UVHjKkaI2vNXDXi8a5NfAziFV8Qruv0Eo25qkbD0BI130_provenance.